Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Glynn

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Biochimica Et Biophysica Acta|August 21, 2012
Neuronal phospholipid deacylation is essential for axonal and synaptic integrityPaul Glynn
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|July 25, 2003
NTE: one target protein for different toxic syndromes with distinct mechanisms?Paul Glynn
Toxicology Letters|November 29, 2005
A mechanism for organophosphate-induced delayed neuropathyPaul Glynn
Biochimica Et Biophysica Acta|September 3, 2005
Neuropathy target esterase and phospholipid deacylationPaul Glynn
Arhiv Za Higijenu Rada I Toksikologiju|December 7, 2007
Axonal degeneration and neuropathy target esterasePaul Glynn
Biochemical Pharmacology|May 16, 2020
β1-adrenoceptor-stimulated lactate production in cultured astrocytes is predominantly glycogen-independentXianguo Jiang, John Challiss, Paul Glynn
The Journal of Biological Chemistry|January 7, 2003
Protein domains, catalytic activity, and subcellular distribution of neuropathy target esterase in Mammalian cellsYong Li, David Dinsdale, Paul Glynn
Neurotoxicology|January 12, 2021
Dr Martin Keith Johnson 1930-2018Ted Lock, Andrew Smith, Paul Glynn
Journal of Shoulder and Elbow Surgery|March 20, 2009
Psychometric properties of the shortened disabilities of the Arm, Shoulder, and Hand Questionnaire (QuickDASH) and Numeric Pain Rating Scale in patients with shoulder painPaul E Mintken, Paul Glynn, Joshua A Cleland
Biochemistry|March 24, 2004
The mipafox-inhibited catalytic domain of human neuropathy target esterase ages by reversible proton lossTimothy J Kropp, Paul Glynn, Rudy J Richardson
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Biochimica Et Biophysica Acta|August 21, 2012
Neuronal phospholipid deacylation is essential for axonal and synaptic integrityPaul Glynn
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|July 25, 2003
NTE: one target protein for different toxic syndromes with distinct mechanisms?Paul Glynn
Toxicology Letters|November 29, 2005
A mechanism for organophosphate-induced delayed neuropathyPaul Glynn
Biochimica Et Biophysica Acta|September 3, 2005
Neuropathy target esterase and phospholipid deacylationPaul Glynn
Arhiv Za Higijenu Rada I Toksikologiju|December 7, 2007
Axonal degeneration and neuropathy target esterasePaul Glynn
Biochemical Pharmacology|May 16, 2020
β1-adrenoceptor-stimulated lactate production in cultured astrocytes is predominantly glycogen-independentXianguo Jiang, John Challiss, Paul Glynn
The Journal of Biological Chemistry|January 7, 2003
Protein domains, catalytic activity, and subcellular distribution of neuropathy target esterase in Mammalian cellsYong Li, David Dinsdale, Paul Glynn
Neurotoxicology|January 12, 2021
Dr Martin Keith Johnson 1930-2018Ted Lock, Andrew Smith, Paul Glynn
Journal of Shoulder and Elbow Surgery|March 20, 2009
Psychometric properties of the shortened disabilities of the Arm, Shoulder, and Hand Questionnaire (QuickDASH) and Numeric Pain Rating Scale in patients with shoulder painPaul E Mintken, Paul Glynn, Joshua A Cleland
Biochemistry|March 24, 2004
The mipafox-inhibited catalytic domain of human neuropathy target esterase ages by reversible proton lossTimothy J Kropp, Paul Glynn, Rudy J Richardson
Pageof 3